Insiders · Profile

Grygiel Nancy A.

SVP & CCO at Amgen. Filing since 11 May 2021. CIK 0001816414

Company
Date
Role
Action
Shares
Amount
Of holding
6 Aug 2026
SVP & CCO
Sold at will
2,970
$1.19M
28.8%
4 May 2026
SVP & CCO
Sold at will
1,237
$400.45K
15.0%
20 Nov 2025
SVP & CCO
Sold at will
3,139
$1.06M
30.3%
20 Aug 2025
SVP & CCO
Sold at will
1,267
$376.28K
14.9%
5 Feb 2025
SVP & CCO
Sold at will
1,589
$483.81K
18.1%
3 May 2024
SVP & CCO
Sold at will
2,117
$662.80K
17.6%
4 Dec 2023
SVP & CCO
Sold at will
2,096
$572.28K
16.2%
8 Nov 2022
SVP & CCO
Sold, plan not stated
545
$159.98K
4.0%
11 May 2021
SVP & CCO
Sold, plan not stated
2,500
$631.27K
16.7%
9 decisions on file.